Adams Respiratory Therapeutics

Adams Respiratory Therapeutics is the maker behind Mucinex, one of the most recognized names in over-the-counter respiratory relief. This collection centers on that expertise, featuring Adams Respiratory Therapeutics Mucinex Cold and Cough Relief in a 600 mg extended-release tablet, packaged 500 tablets per bottle (NDC 63824000850) — a case-quantity format built for pharmacies, clinics, and facilities that dispense regularly rather than a single retail blister pack.

The active ingredient, guaifenesin, works as an expectorant: it thins and loosens mucus in the airways so it can be cleared more easily, easing chest congestion that comes with the common cold, bronchitis, and other respiratory conditions. The extended-release formulation is designed to deliver relief over a longer window than immediate-release guaifenesin, which is why the 600 mg strength is a staple for both self-care and provider-directed use.

Buyers stocking this product are usually weighing bottle economics and shelf turnover. A 500-count bottle lowers the per-tablet cost compared with consumer packs and reduces reordering frequency for high-traffic settings — but it also means paying attention to expiration dating and proper storage in a cool, dry place to protect potency across a larger supply. For anyone managing an OTC formulary, guaifenesin is a reliably low-interaction expectorant, though patients with persistent cough lasting more than a week, or cough accompanied by fever, rash, or headache, should be directed to a clinician.

Adams also has roots in the broader consumer-goods world through its confectionery lineage. If you're looking for that side of the brand's history, see our Cadbury Adams USA collection. For respiratory care, the Mucinex expectorant here remains the practical, evidence-backed choice for congestion relief at scale.